Cargando…
The Peritoneal Membrane—A Potential Mediator of Fibrosis and Inflammation among Heart Failure Patients on Peritoneal Dialysis
Peritoneal dialysis is a feasible, cost-effective, home-based treatment of renal replacement therapy, based on the dialytic properties of the peritoneal membrane. As compared with hemodialysis, peritoneal dialysis is cheaper, survival rate is similar, residual kidney function is better preserved, fl...
Autores principales: | Kunin, Margarita, Beckerman, Pazit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954812/ https://www.ncbi.nlm.nih.gov/pubmed/35323792 http://dx.doi.org/10.3390/membranes12030318 |
Ejemplares similares
-
Effect of Peritoneal Dialysis on Serum Fibrosis Biomarkers in Patients with Refractory Congestive Heart Failure
por: Kunin, Margarita, et al.
Publicado: (2019) -
Optimal peritoneal fluid white blood cell count for diagnosis of peritonitis in peritoneal dialysis patients
por: Kunin, Margarita, et al.
Publicado: (2023) -
Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
por: Masola, Valentina, et al.
Publicado: (2022) -
Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis
por: Kunin, Margarita, et al.
Publicado: (2015) -
New Developments in Peritoneal Fibroblast Biology: Implications for Inflammation and Fibrosis in Peritoneal Dialysis
por: Witowski, Janusz, et al.
Publicado: (2015)